Cargando…
The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L- norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum
N-acetyl-L-leucyl-L-leucyl-L-norleucinal, (LLnL), which inhibits proteasomes in addition to other proteases, was found to prolong the association of major histocompatibility complex class I molecules with the transporters associated with antigen processing (TAP), and to slow their transport out of t...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192528/ https://www.ncbi.nlm.nih.gov/pubmed/8666915 |
Ejemplares similares
-
Crystal structure of N-{N-[N-acetyl-(S)-leucyl]-(S)-leucyl}norleucinal (ALLN), an inhibitor of proteasome
por: Czerwinski, Andrzej, et al.
Publicado: (2015) -
Standard
Thermodynamic Functions of Tripeptides N-Formyl-l-methionyl-l-leucyl-l-phenylalaninol and N-Formyl-l-methionyl-l-leucyl-l-phenylalanine Methyl
Ester
por: Markin, Alexey V., et al.
Publicado: (2014) -
N-Methyl-l-leucyl-l-leucine hydrochloride monohydrate
por: Lu, Tao, et al.
Publicado: (2011) -
N-{N-[N-(1,1-Dimethylethoxycarbonyl)-l-leucyl]-N-methyl-l-leucyl}-N-methyl-l-leucine benzyl ester
por: Xu, Wen Jie, et al.
Publicado: (2008) -
Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling
por: Zhang, Yunjing, et al.
Publicado: (2018)